UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Macrogen wins patent for fusion genes that causes lung adenocarcinoma
Macrogen said that it has registered a patent for AXL-MBIP, a fusion gene t...
by Lee Han-soo
|
2019-10-28 17:08
라인
Hanall posts ₩28 billion in Q3 sales
HanAll Biopharma said that it recorded 28 billion won ($23.9 million) in sa...
by Lee Han-soo
|
2019-10-28 17:08
라인
'Development of new psoriasis treatments good news for patients'
Development of new psoriasis treatments is helping psoriasis patients both ...
by Lee Han-soo
|
2019-10-28 13:56
라인
Korea should import new drug to treat pulmonary arterial hypertension
Physicians have raised voice for importing new drugs to treat pulmonary art...
by Kim Yun-mi
|
2019-10-25 18:08
라인
Hanmi’s US partner resubmits BLA application for neutropenia treatment
Spectrum, Hanmi Pharmaceutical’s U.S. partner, said Friday that it has resu...
by Lee Han-soo
|
2019-10-25 17:36
라인
'Pharmacovigilance as crucial as clinical trials'
The importance of pharmacovigilance, which is the task of collecting and an...
by Lee Han-soo
|
2019-10-24 18:21
라인
Daewoong releases trial data on gastroesophageal reflux disease drug
Daewoong Pharmaceutical said that it has presented its phase 1 multiracial ...
by Lee Han-soo
|
2019-10-24 17:00
라인
Novartis’ Cosentyx strengthens position as comprehensive psoriasis treatment
Novartis said it presented the long-term real-world evidence data for Cosen...
by Lee Han-soo
|
2019-10-24 14:47
라인
AbbVie draws favorable rating for its rheumatism drug in Europe
AbbVie Korea said the European Medicines Agency's Committee for Medicin...
by Lee Han-soo
|
2019-10-24 14:45
라인
PharmAbcine sets up US unit to develop anticancer drug
PharmAbcine said it would speed up the development of a new anticancer drug...
by Jeong Sae-im
|
2019-10-23 15:48
라인
Pfizer Korea reaffirms corporate missions on 50th anniversary
Under the corporate slogan of “breakthroughs that change patients' live...
by Lee Han-soo
|
2019-10-23 14:53
라인
Gemvax & Kael's GV1001 shows efficacy as prostate cancer treatment
Gemvax & Kael said that it has confirmed the efficacy of GV1001 in treating...
by Lee Han-soo
|
2019-10-23 10:59
라인
Pfizer’s atopic drug should overcome side effects to challenge Sanofi’s Dupixent
Pfizer recently proved the efficacy of its investigational atopic dermatiti...
by Kim Yun-mi
|
2019-10-22 14:17
라인
Pharma industry hits government steps regarding ranitidine ban
The local pharmaceutical industry is expressing its distrust and displeasur...
by Lee Han-soo
|
2019-10-21 17:16
라인
Dong-A ST leaves KPBMA to ‘repent of illegal rebate’
Dong-A ST is voluntarily giving up its membership of the Korea Pharmaceutic...
by Jeong Sae-im
|
2019-10-21 16:42
라인
GSK applies for additional indication of asthma inhaler Trelegy Ellipta
GSK said that it has applied to obtain an additional indication for Trelegy...
by Lee Han-soo
|
2019-10-21 15:32
라인
Drug firms’ Q3 earnings to be fairly good
Korea’s large pharmaceutical companies are expected to have yielded good ea...
by Jeong Sae-im
|
2019-10-21 12:27
라인
Regulator OKs Jeil's advanced colorectal cancer treatment
Jeil Pharmaceutical said that the Ministry of Food and Drug Safety has appr...
by Lee Han-soo
|
2019-10-21 11:38
라인
Ministry OKs ATGC's p1, 2 trial for BTX
ATGC, a local biopharmaceutical firm, said that the Ministry of Food and Dr...
by Lee Han-soo
|
2019-10-18 18:23
라인
Physicians feel burdened by Ranitidine ban: survey
Nearly half of doctors have encountered difficulties with patients over the...
by Lee Han-soo
|
2019-10-18 16:48
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top